Login / Signup

Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.

Eva ZhangThi H O NguyenLilith F AllenLukasz KedzierskiLouise C RowntreeSo Young ChangWuji ZhangJennifer R HabelIsabelle J FooTejas MenonJeni MitchellRupert W L LeongKatherine BondDeborah A WilliamsonKatherine KedzierkaBritt Christensen
Published in: Gut (2023)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • rheumatoid arthritis
  • coronavirus disease